Polysaccharide Conjugate Vaccines for the Prevention of Gram-Positive Bacterial Infections
- 1 January 1996
- book chapter
- Published by Springer Nature
- Vol. 397, 133-140
- https://doi.org/10.1007/978-1-4899-1382-1_18
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prevention of Systemic Infections Caused by Group B Streptococcus and Staphylococcus aureus by Multivalent Polysaccharide‐Protein Conjugate VaccinesAnnals of the New York Academy of Sciences, 1995
- Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991Infection Control & Hospital Epidemiology, 1992
- Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989The American Journal of Medicine, 1991
- Structure of the type 5 capsular polysaccharide of Staphylococcus aureusCarbohydrate Research, 1990
- Polysaccharide-Protein Conjugates: A New Generation of VaccinesThe Journal of Infectious Diseases, 1990
- Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureusDiagnostic Microbiology and Infectious Disease, 1984